Frontier Capital Management CO LLC Nevro Corp Transaction History

Frontier Capital Management CO LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$58.04 - $66.99 $3.91 Million - $4.51 Million	-67,364 Closed	0 $0
Q1 2019 May 07, 2019	BUY	$35.52 - $62.62 $2.39 Million - $4.22 Million	67,364 New	67,364 $4.21 Million
Q3 2018 Oct 30, 2018	SELL	$44.22 - $75.47 $18.8 Million - $32 Million	-424,427 Closed	0 $0
Q2 2018 Aug 03, 2018	SELL	$72.38 - $92.5 $29.5 Million - $37.7 Million	-407,359 Reduced 48.97%	424,427 $33.9 Million
Q1 2018 Apr 30, 2018	SELL	$69.46 - $88.57 $3.86 Million - $4.93 Million	-55,616 Reduced 6.27%	831,786 $72.1 Million

Q4 2017 Jan 18, 2018	BUY	$65.94 - $93.31 $8.28 Million - $11.7 Million	125,632 Added 16.49%	887,402 $61.3 Million
Q3 2017 Oct 31, 2017	BUY	$80.87 - $91.08 $61.6 Million - $69.4 Million	761,770	761,770 $69.2 Million

174

37.4M

80.4K

898K

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $298M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Frontier Capital Management CO LLC, based on Form 13F filings with the SEC.

Stay updated on Frontier Capital Management CO LLC with notifications on news.